Dr Reddys Laboratories share price

ABOUT Dr Reddys Laboratories

• Industry Biotechnology & Drugs
• ISIN INE089A01023
• BSE Code 500124
• NSE Code DRREDDY

Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.

Dr Reddys Laboratories Management

• Kallam Reddy Chairman of the Board
• Gunupati Prasad Co-Chairman of the Board, Managing Director
• Erez Israeli Chief Executive Officer
• Parag Agarwal Chief Financial Officer
• Patrick Aghanian Chief Executive Officer, European Generics
• Marc Kikuchi Chief Executive Officer, North America Generics
• M. Ramana Chief Executive Officer, Branded Markets (India and Emerging Markets)
• Deepak Sapra Chief Executive Officer, API and Services
• Archana Bhaskar Chief Human Resource Officer
• Phanimitra B. Chief Information Officer